| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.054 | 0.2 |